NextSense Raises $16M Series A for In-Ear EEG Smartbuds for Brain Health
Summary
NextSense has raised $16 million in an oversubscribed Series A led by Ascension Ventures with Satori Neuro and Corundum Neuroscience Fund joining. The company is developing clinically accurate wireless earbuds with built-in EEG sensors for brain health and sleep monitoring. Founded by a former lead at Alphabet's X division, NextSense frames its mission as democratizing brain health in the way wearables once democratized heart-rate tracking. The Smartbuds are designed for all-night wear capturing brain activity continuously during sleep.
Why it matters
NextSense's approach of embedding EEG sensors into a familiar consumer form factor addresses one of the biggest barriers to widespread brain health monitoring: user comfort and adherence. By turning earbuds into clinical-grade brain sensors, the company could dramatically expand the addressable market for neurodiagnostics beyond sleep labs and neurology clinics. The $16M Series A for a consumer neurotechnology device shows continued investor interest in making brain monitoring as routine as tracking steps or heart rate.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial